Cooper Companies Inc
The Cooper Companies operates in the Health Care Equipment & Supplies industry, generating revenue through its subsidiaries including CooperVision and CooperSurgical, which provide vision care and surgical products globally.
Business. The Cooper Companies Inc (COO.O) is a health care equipment and supplies manufacturer that operates within the Health Care sector. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Company
- EarningsQ3 2026 earnings (expected)2026-08-28 · estimated
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Cooper Companies Inc (COO.O) has entered the scope of this analysis, marking the first available data point for the ticker with no prior basis for computing historical deltas. As a result, the current snapshot serves as the foundational baseline for future monitoring of the company’s financial and ownership dynamics. The most significant activity observed involves substantial modifications to the holdings of investor ID 587. Data indicates a major shift in share count for this investor as of March 31, 2026, with records showing the position fluctuating between 832 shares and 61,508 shares. These changes, detected in late June and early July 2026, represent a dramatic alteration in the investor's stake, swinging from a negligible weight of approximately 0.00003% to a more substantial 0.25% of the company. In addition to these major modifications, a notable new holding was recorded for investor ID 933. As of September 30, 2022, this investor held 86,091 shares, representing a portfolio weight of roughly 3.37%. This addition highlights ongoing interest from institutional or significant holders, contributing to the broader landscape of the company's shareholder base. Cooper Companies Inc currently maintains a profile with one listed officer and membership in one index, supported by a top holder count of 37. With zero analyst coverage currently recorded, the company’s valuation and outlook rely heavily on these ownership signals and fundamental data rather than consensus estimates. The recent volatility in major holder positions underscores the importance of monitoring these shifts as key indicators of investor sentiment.
Signals & dispatch
Composite-score breakdown
Synthesis
The Cooper Companies Inc (COO.O) is a health care equipment and supplies manufacturer that operates within the Health Care sector. The company is headquartered in the United States and is primarily listed on the NASDAQ exchange. Specific details regarding its operating segments and geographic revenue mix are not provided in the available data.
The company maintains a conservative capital structure with a debt-to-equity ratio of 0.3, indicating limited leverage relative to shareholder equity. Total liabilities stand at $4.16 billion against total assets of $12.39 billion, resulting in a net debt position after accounting for $110.6 million in cash and equivalents. The current liquidity profile is assessed as medium risk, supported by operating cash flow of $796.1 million, which comfortably covers capital expenditures of $362.4 million. The price-to-book ratio of 1.63 suggests the market values the company slightly above its tangible book value, while the EV/EBITDA multiple of 23.09 reflects a premium valuation relative to earnings before interest, taxes, depreciation, and amortization.
Profitability metrics indicate modest returns, with a return on equity of 4.55% and a return on assets of 3.02%. The net income of $374.9 million represents a net margin of approximately 9.16% on revenue of $4.09 billion. Operating income of $682.9 million suggests effective cost control, yielding an operating margin of roughly 16.7%. These returns are generated from a gross profit of $2.68 billion, implying a gross margin of approximately 65.5%, which is typical for specialized medical device and consumable manufacturers. The valuation snapshot shows a P/E ratio of 35.8, indicating that investors are pricing in future growth expectations despite current moderate return metrics.
Revenue generation is supported by a global network of subsidiaries, including CooperVision Sarl, CooperVision RUS LLC, CooperVision Israel Ltd, and CooperSurgical, Inc. The presence of entities in Russia, Israel, and other international jurisdictions suggests significant geographic diversification beyond the domestic market. The subsidiary structure indicates a fragmented operational footprint that likely serves distinct regional markets for contact lenses, surgical instruments, and other health care supplies. This global exposure provides revenue stability but also introduces operational complexity across different regulatory environments.
Growth trajectory analysis is limited by the absence of historical period data in the current input. However, the current revenue base of $4.09 billion provides a substantial scale for incremental growth. The company’s ability to maintain positive operating cash flow of $796.1 million suggests resilience in cash generation, which can be reinvested into R&D or used for share repurchases. Without historical trend data, the sustainability of current revenue levels must be inferred from the stability of the balance sheet and the consistent generation of operating income.
Risk assessment highlights medium liquidity risk and low dilution risk. The key flag notes that net cash is negative after subtracting total debt, which is a standard condition for leveraged firms but requires monitoring of interest coverage. The low dilution risk is supported by the identical basic and diluted share counts of 195.9 million, indicating no significant outstanding options or convertible securities that would erode shareholder value in the near term. The primary financial risk lies in the management of long-term debt of $2.46 billion, which must be serviced by operating cash flows.
Recent observations include reconciler events indicating zero analysis jobs for the company, which is an internal processing note rather than a business event. The IR observations confirm the corporate structure through EDGAR filings, listing various subsidiaries with high confidence. There are no specific news events, filing observations, or transcript observations provided that indicate recent strategic shifts, mergers, or regulatory actions. The absence of recent material news suggests a stable operational environment without immediate catalysts or disruptions.
Cooper Companies Inc (COO.O) has entered the scope of this analysis, marking the first available data point for the ticker with no prior basis for computing historical deltas. As a result, the current snapshot serves as the foundational baseline for future monitoring of the company’s financial and ownership dynamics. The most significant activity observed involves substantial modifications to the holdings of investor ID 587. Data indicates a major shift in share count for this investor as of March 31, 2026, with records showing the position fluctuating between 832 shares and 61,508 shares. These changes, detected in late June and early July 2026, represent a dramatic alteration in the investor's stake, swinging from a negligible weight of approximately 0.00003% to a more substantial 0.25% of the company. In addition to these major modifications, a notable new holding was recorded for investor ID 933. As of September 30, 2022, this investor held 86,091 shares, representing a portfolio weight of roughly 3.37%. This addition highlights ongoing interest from institutional or significant holders, contributing to the broader landscape of the company's shareholder base. Cooper Companies Inc currently maintains a profile with one listed officer and membership in one index, supported by a top holder count of 37. With zero analyst coverage currently recorded, the company’s valuation and outlook rely heavily on these ownership signals and fundamental data rather than consensus estimates. The recent volatility in major holder positions underscores the importance of monitoring these shifts as key indicators of investor sentiment.
- The company generates $4.09 billion in revenue with a strong gross margin of ~65.5%, driven by its vision care and surgical product segments.
- Leverage is conservative with a debt-to-equity ratio of 0.3, though net cash is negative due to $2.46 billion in long-term debt.
- Returns are modest with ROE at 4.55% and ROA at 3.02%, trading at a premium P/E of 35.8 and EV/EBITDA of 23.09.
- Dilution risk is low, as basic and diluted share counts are identical at 195.9 million shares.
- Global subsidiary structure indicates diversified geographic exposure, including entities in Russia and Israel, which may introduce geopolitical considerations.
- Operating cash flow of $796.1 million exceeds capital expenditures of $362.4 million, providing free cash flow for debt service or reinvestment.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 4,63 |
| Revenue | —no estimate | —no estimate | 4,3B USD |
| Operating income | —no estimate | —no estimate | 1,1B USD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Derivative transactions
- Director · Restricted Stock Units → Common StockAcquired 2 814grant · 2026-07-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 832exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 654exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 4 157grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 050exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
- Director · Restricted Stock Units → Common StockAcquired 3 779grant · 2026-04-01
- Director · Restricted Stock Units → Common StockDisposed 3 322exercise · 2026-04-01
- Director · Stock Options (Right to Buy) → Common StockDisposed 7 064 @ $39,40exercise · 2026-01-12
- President, CooperVision, Inc. · Restricted Stock Units → Common StockDisposed 1 232exercise · 2026-01-08
- EVP, CFO & Treasurer · Restricted Stock Units → Common StockDisposed 3 528exercise · 2026-01-08
- EVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 163exercise · 2026-01-08
- EVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 556exercise · 2026-01-08
- EVP & Chief Operating Officer · Restricted Stock Units → Common StockDisposed 4 168exercise · 2026-01-08
- President, CSI · Restricted Stock Units → Common StockDisposed 3 154exercise · 2026-01-08
- President, CSI · Restricted Stock Units → Common StockDisposed 3 304exercise · 2026-01-08
Actions
Ask Handelsavisen
- Reference data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Price To Tangible Bookmarket_price / (tangible_book_value / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Return On Equitynet_income / total_equity
- Enterprise Valuemarket_cap - net_cash
- Ev To Revenueenterprise_value / revenue
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- The Cooper Companies, Inc. Market data — financials · 2026-07-28
- reconciler_enqueue (reconciler) on COO.O · 2026-07-28
- Cooper Companies Inc HA canonical relationships · 2026-07-28
Ownership & reference
Top holders
- Investment Managers · as of 2026-03-310,45 %$1M
- Investment Managers · as of 2026-03-310,12 %$261M
- Institutional Investor · as of 2026-03-310,11 %$219M
- Investment Managers · as of 2026-03-310,09 %$348M
- Investment Managers · as of 2026-03-310,08 %$152M
- Investment Managers · as of 2026-03-310,07 %$530M
- Institutional Investor · as of 2026-03-310,07 %$211M
- Investment Managers · as of 2026-03-310,04 %$241M
- Investment Managers · as of 2026-03-310,04 %$0M
- Investment Managers · as of 2026-03-310,04 %$246M
- Funds · as of 2026-03-310,04 %$261M
- Investment Managers · as of 2024-06-300,03 %$1 519M
- Institutional Investor · as of 2022-09-300,03 %$0M
- Investment Managers · as of 2026-03-310,03 %$148M
- Investment Managers · as of 2025-12-310,03 %$1 930M
- Investment Managers · as of 2026-03-310,02 %$378M
- Investment Managers · as of 2024-12-310,02 %$81M
- Investment Managers · as of 2026-03-310,02 %$627M
- Investment Managers · as of 2026-03-310,02 %$129M
- Brokerage Firms · as of 2026-03-310,02 %$88M
- Investment Managers · as of 2026-03-310,02 %$127M
- Brokerage Firms · as of 2026-03-310,02 %$54M
- Institutional Investor · as of 2026-03-310,01 %$79M
- Institutional Investor · as of 2026-03-310,01 %$20M
- Institutional Investor · as of 2026-03-310,01 %$39M
- Investment Managers · as of 2026-03-310,01 %$17M
- Investment Managers · as of 2026-03-310,01 %$137M
- Investment Managers · as of 2026-03-310,01 %$57M
- Investment Managers · as of 2026-03-310,01 %$9M
- Investment Managers · as of 2026-03-310,01 %$16M
- Investment Managers · as of 2026-03-310,00 %$5M
- Investment Managers · as of 2026-03-310,00 %$10M
- Investment Managers · as of 2026-03-310,00 %$4M
- Investment Managers · as of 2026-03-310,00 %$4M
- Institutional Investor · as of 2026-03-310,00 %$35M
- Investment Managers · as of 2026-03-310,00 %$1M
- Investment Managers · as of 2026-03-310,00 %$0M
Leadership
- Albert G. WhitePresident, Chief Executive Officer, Director
Insider activity
- Director · Common StockOther 3 322 · 2026-04-01
- Director · Common StockOther 3 322 · 2026-04-01
- Director · Common StockOther 3 322 · 2026-04-01
- Director · Common StockOther 3 322 · 2026-04-01
- Director · Common StockOther 3 050 · 2026-04-01
- Director · Common StockOther 3 322 · 2026-04-01
- Director · Common StockOther 832 · 2026-04-01
- Director · Common StockOther 3 654 · 2026-04-01
- Director · Common StockOther 7 064 @ $39,40$278K · 2026-01-12
- President, CooperVision, Inc. · Common StockOther 1 540 · 2026-01-08
- Director, President & CEO · Common StockOther 18 340 · 2026-01-08
- Director, President & CEO · Common StockOther 9 419 @ $83,13$783K · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 2 652 · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 3 154 · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 1 232 · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 2 940 · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 1 714 @ $83,13$142K · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 629 @ $83,13$52K · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 787 @ $83,13$65K · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 1 501 @ $83,13$125K · 2026-01-08
- President, CooperVision, Inc. · Common StockOther 1 354 @ $83,13$113K · 2026-01-08
- President, CSI · Common StockOther 3 154 · 2026-01-08
- President, CSI · Common StockOther 1 592 · 2026-01-08
- President, CSI · Common StockOther 3 304 · 2026-01-08
- President, CSI · Common StockOther 1 462 @ $83,13$122K · 2026-01-08
Short positioning
Geographic breakdown
Intel & risk
Evidence & claims
From filings & derived data- Long-term debt (annual): USD 1.88BUnknown
- Shares outstanding (annual): 195.1MUnknown
- Cash & equivalents (annual): USD 124.9MUnknown
- Total liabilities (annual): USD 4.06BUnknown
- Total assets (annual): USD 12.42BUnknown
- Shareholders' equity (annual): USD 8.36BUnknown
- Current liabilities (annual): USD 1.6BUnknown
- Current assets (annual): USD 2.13BUnknown
- Gross profit (annual): USD 2.68BUnknown
- Operating cash flow (annual): USD 796.1MUnknown
- Net income (annual): USD 374.9MUnknown
- Operating income (annual): USD 682.9MUnknown
- Revenue (annual): USD 4.09BUnknown
- Capex (annual): USD 362.4MUnknown
- Cost of revenue (annual): USD 1.41BUnknown
- EPS (diluted) (annual): USD-PER-SHARES 2Unknown
- Pre-tax income (annual): USD 566.5MUnknown
- EPS (basic) (annual): USD-PER-SHARES 2Unknown
- R&D expense (annual): USD 172.2MUnknown
- Long-term debt (annual): USD 2.49BUnknown
- Shareholders' equity (annual): USD 8.13BUnknown
- Shares outstanding (annual): 199.9MUnknown
- Current liabilities (annual): USD 999.6MUnknown
- Current assets (annual): USD 1.99BUnknown